NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128583&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128459&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128586&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128587&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128588&wire=1 or contact Joseph E. Levi, Esq.

SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Napco Security Technologies, Inc. (NASDAQ: NSSC) saw its shares tumble after the company reported a sharp decline in second-quarter 2025 earnings, revealing problems with its distribution network. The news reignited concerns about the company's sales practices, previously raised by a research report last September.

ASML's AI-driven demand, High-NA EUV dominance, and solid execution support a 33% two-year price CAGR, despite near-term China risks, making it a compelling buy even at current levels. Strong Q4 results, stable 2025 guidance, and long-term projections (€44-60B revenue by 2030) reinforce ASML's leadership, with expanding gross margins and robust free cash flow generation. Geopolitical risks persist, but AI tailwinds, TSMC/Samsung demand, and High-NA EUV rollout secure ASML's position as the premier lithography supplier—current valuation remains highly attractive.

Clorox (CLX -0.86%) is down 10.1% year to date at the time of this writing, with most of that drop occurring last week when the company reported second-quarter fiscal 2025 results. The maker of bleach, Kingsford charcoal, Hidden Valley Ranch, Burt's Bees, and more has been on a roller coaster in recent years, but the end of its turnaround is finally in sight.

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today reported unaudited financial results for its third quarter ended December 31, 2024, and recent business highlights. “As we advance our lead clinical programs, CYB003 and CYB004, our focus in 2025 remains on continued.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Block, Inc. (NYSE:XYZ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/block-inc-lawsuit-submission-form-2?prid=128577&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=128580&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edison International ("Edison International") (NYSE:EIX) concerning possible violations of federal securities laws. On January 12, 2025, the Los Angeles Times published an article, "Officials investigating whether Southern California Edison equipment ignited Hurst fire.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128582&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128578&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128579&wire=1 or contact Joseph E. Levi, Esq.

BYD Co. will enable advanced driver-assistance features in almost all future models at no additional cost to buyers as part of a bid to challenge Tesla Inc. and domestic rivals in China's cutthroat electric-vehicle market. It also plans to integrate software from DeepSeek, without specifying when that would happen.

Bill Ackman is one of the most widely followed investment managers in the world. He's in charge of Pershing Square Capital, a hedge fund focused on investing in just a handful of Ackman's best ideas.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR ) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis - SVP & Head of Global Cardio/Metabolic Franchise James Hamilton - Chief Discovery & Translational Medicine Ken Myszkowski - CFO Conference Call Participants Luca Issi - RBC Capital David Lebowitz - Citi Jasmine Fels - UBS Maury Raycroft - Jefferies Edward Tenthoff - PSC Patrick Trucchio - H.C. Wainwright Mayank Mamtani - B.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Red Cat Holdings, Inc. (NASDAQ: RCAT) resulting from allegations that Red Cat may have issued materially misleading business information to the investing public.

The great Warren Buffett might have popularized value investing. But a lot of investors out there want to own businesses that are increasing revenue at a solid clip.